Recent Finacing
Recent Raise
Clementia Pharmaceuticals is a clinical-stage biopharmaceutical company developing palovarotene, a retinoic acid receptor gamma agonist licensed from Roche, for fibrodysplasia ossificans progressiva and heterotopic ossification, conducting Phase 2 trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors